Home FDA probes cognitive impact of new cholesterol drugs
 

Keywords :   


FDA probes cognitive impact of new cholesterol drugs

2014-03-08 17:04:55| Biotech - Topix.net

T he Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.

Tags: impact drugs cognitive cholesterol

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11dura ace 32H
25.11 (S)
25.111592 33mm 33mm
25.11 DVD 7
25.11DR4270
25.11A +A act2
25.115 SEED FREEDOM
25.11
More »